LiDCO Group Plc

LID

GB0030546849

Advanced Medical Equipment & Technology

Delayed London S.E. Other stock markets 11:35:19 2021-01-08 EST			5-day change	1st Jan Change
11.75 ^GBX	-.--%		-.--%	-.--%

2020	Masimo Corporation completed the acquisition of LiDCO Group Plc from Herald Investment Management Limited, Eiffel Investment Group S.A.S., Vermeer Partners, P Brewer and others.	CI
2020	LiDCO : Takeover Offer by Masimo Declared Unconditional, Acceptances Exceed 90%	MT

LiDCO Signs an Exclusive Three Year Agreement with Merit Medical Japan to Distribute Lidco Products in Japan

January 17, 2018 at 02:00 am

LiDCO announced that it has signed an exclusive three year agreement with Merit Medical Japan to distribute LiDCO products in Japan.

Latest news about LiDCO Group Plc

Masimo Corporation completed the acquisition of LiDCO Group Plc from Herald Investment Management Limited, Eiffel Investment Group S.A.S., Vermeer Partners, P Brewer and others.	20-12-30	CI
LiDCO : Takeover Offer by Masimo Declared Unconditional, Acceptances Exceed 90%	20-12-08	MT
LiDCO : Masimo's Takeover Offer for LiDCO Extended for Two Weeks as Acceptances Reach 75%	20-11-24	MT
LiDCO : Surges 68% on Acquisition by Masimo in $40 Million Deal	20-11-02	MT
Masimo Corporation reached agreement on the terms of a recommended cash offer to acquire LiDCO Group Plc from Herald Investment Management Limited, Eiffel Investment Group S.A.S., Vermeer Partners, P Brewer and others for £30.4 million.	20-11-01	CI
LiDCO Group Plc Provides Sales Guidance for the Second Half of Financial Year Ending January 31, 2021	20-10-13	CI
Lidco Group plc Reports Earnings Results for the Half Year Ended July 31, 2020	20-10-13	CI
LiDCO Group Plc Provides Sales Guidance for the Three Months Ending 30 April 2020	20-04-21	CI
Lidco Group plc Reports Earnings Results for the Full Year Ended January 31, 2020	20-04-21	CI
LiDCO Group plc Reports Revenues Results for the Full Year Ended 31 January 2020	20-02-13	CI
LiDCO Group Plc Announces LiDCOrapidv3 Launched in China	19-11-05	CI
Lidco Group plc Reports Earnings Results for the Half Year Ended July 31, 2019	19-10-15	CI
LiDCO Signs Variation Agreement to Existing Commercial Collaboration with Cnsystems Medizintechnik AG	19-09-12	CI
LiDCO Group plc Appoints James G. Wetrich to the Board, as A Non-Executive Director	19-08-15	CI
LiDCO Announces Latest Cardiac Output Monitor with Non-Invasive Technology Has Received Regulatory Approval for Commercial Sale in China	19-07-16	CI
LiDCO Group Plc Announces Revenue Results for the First Quarter Ended April 30, 2019	19-05-16	CI
LiDCO Group Plc Announces Regulatory Approval in South Korea	19-04-17	CI
LiDCO Group plc Announces Audited Consolidated Earnings Results for the Full Year Ended January 31, 2019; Provides Revenue Guidance for the Full Year of Fiscal 2019/2020	19-03-26	CI
LiDCO Group plc Wins 5 Year Contract	19-03-08	CI
LiDCO Group plc Announces Executive Changes	19-03-05	CI
LiDCO Group plc Reports Revenue Results for the Year Ended January 31, 2019	19-02-20	CI
LiDCO Group plc Provides Earnings Guidance for the Full Year Ending 31 January 2019	18-12-17	CI
LiDCO Group plc Reports Unaudited Consolidated Earnings Results for the Six Months Ended July 31, 2018	18-10-09	CI
LiDCO Group plc Announces UK Distribution Agreement with Shenzhen Shenzhen Antmed Co.,Ltd	18-10-09	CI
Jill McGregor, Chief Financial Officer to Leave LiDCO Group plc	18-09-24	CI

Lidco Group Ltd, formerly LiDCO Group Plc, is a United Kingdom-based supplier of non-invasive and minimally invasive hemodynamic monitoring equipment to hospitals. The Company is engaged in the development, manufacture and sale of cardiac monitoring equipment. It operates in the segment of supply of monitors, consumables and support services associated with the use of its cardiac monitoring equipment. The Company's products include LiDCOplus, a computer-based platform monitor; LiDCOrapid, a cardiac output monitor; LiDCOview, a graphical display, and LiDCOunity, which is its hemodynamic monitor. Its LiDCOrapid is designed for multi-parameter monitoring of both depth of anesthesia and fluids. Its products are used in the treatment of high-risk patients in both critical care units and in the operating theatre. They monitor the amount of blood flowing around the body helping clinicians and nurses to ensure that organs are kept perfused with oxygenated blood.

Sector

Advanced Medical Equipment & Technology

More about the company